1d
Indiatimes on MSNSingle this Valentine's week? Binge watch these romance-free K-dramasDrowning in hearts and romance this Valentine's Week? Even OTT platforms push endless love stories! But not all K-dramas ...
K-drama fans can look forward to upcoming Korean dramas such as Can This Love Be Translated?, Genie, Make a Wish and Cashero ...
Netflix Korea will release 21 scripted series, eight unscripted series and eight original films this year. By Abid Rahman International Editor, Digital Netflix has revealed its 2025 slate of Korean ...
A big month is here for K-drama fans! A diverse and exciting lineup hits the small screens this month. Here are new K-dramas ...
Korean entertainment industry has been dominating cinema worldwide with its intriguing projects that have unique concepts.
Ballerina (2023)in the action-packed thriller Ballerina, directed by lee chung-hyun, jang ok-ju (jeon jong-seo ... the outside world, Joon-woo's fight for survival takes a different turn when he finds ...
Lee Byung Joon is a South Korean actor. He was born in Busan on January 27, 1964 and made his acting debut in 1985. Active in theater, film, and television dramas, he has taken on countless roles ...
Chef Jeon Seong-bin's Samgyetang. Unlike typical Samgyetang, it uses quail for a chewier texture. /Courtesy of Jeon Gi-byeong Vinho's menu, which demonstrates this allure well, features ...
Jake Paul and Mike Tyson party at Trump's inauguration Naoya Inoue retained his undisputed super-bantamweight titles on Friday, with an expected destruction of Ye Joon Kim. Kim was stepping in for ...
Love Scout's Lee Joon Hyuk defeated K-drama competition to top the actors' buzz rankings for two weeks in a row, as the SBS romance remained a fan favourite. SBS TV’s Love Scout is consistently ...
With this upcoming Netflix drama, Lee Joon Hyuk not only returns to his mystery roots but also reunites with a beloved co-star from the hit series, Stranger. Stranger K-drama co-stars Shin Hye Sun ...
Claudin 18.2, or CLDN18.2, is a top target for GI cancer drug research. This past October, Astellas Pharma’s Vyloy became the first FDA-approved CLDN18.2-targeting drug. Vyloy, a monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results